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Objectives: Patient-controlled epidural analgesia (PCEA) and continuous epidural infusion (CEI) are
popular and effective methods for pain relief during labor; however, there are concerns about increasing
rates of cesarean section (C/S) and instrumental delivery. This prospective study investigated the effect of
PCEA and CEI with different formulas on labor and the mode of delivery in nulliparous women.
Materials and methods: A total of 480 nulliparous women were randomized into four groups, with 120 in
each. Group A received a loading dose of 10 mL of 1 mg/mL ropivacaine with 2 mg/mL fentanyl, then an
intermittent bolus of 5mLwith a background infusionof 5mL/hour by PCEA. GroupB received the samePCEA
formula as Group Awith 0.8 mg/mL bupivacaine. Group C received the same formula as Group A by CEI with
1mg/mL ropivacaine at a rate of 10mL/hour. Group D received the same formula as Group Cwith 0.8 mg/mL
bupivacaine. The rates of C/S and instrumental delivery and the incidence of side effects were recorded.
Results: The rates of C/S were signiﬁcantly different between Groups A and C, Groups A and D, and
Groups B and D. The rates of instrumental delivery for normal spontaneous delivery were signiﬁcantly
different between Groups A and B, A and D, B and C, and C and D.
Conclusion: The C/S rate was higher in Groups C and D; however, the instrumental delivery rate was
lower in Groups A and C. We conclude that PCEA with 1 mg/mL ropivacaine might provide the greatest
beneﬁt for labor analgesia.
Copyright  2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Epidural analgesia is a popular and effectivemethod for pain relief
during labor [1e3]. Bupivacaine is a commonly used local anesthetic.
Ropivacaine, an amino acid local anesthetic, is structurally related to
bupivacaine but has less cardiac toxicity, less motor blockade, and a
shorter duration than bupivacaine. It was recently introduced for la-
bor analgesia [4e8]. However, local anesthetics have disadvantages
suchasmaternalmotorblockadeandhypotension. Somestudieshave
investigated the relative potency of ropivacaine and bupivacaine
withorwithoutopioids and theeffects ofmotor and sensoryblockade
[9e14]. One study speciﬁcally addressed the mode of delivery withf interest to declare.
ology, National Taiwan Uni-
Taipei, Taiwan, R.O.C.
n).
bstetrics & Gynecology. Publisheddifferent epidural local anestheticswith regard to obstetric outcomes
but did not ﬁnd a difference between groups [15]. However, no study
simultaneously evaluated the overall rates of cesarean and instru-
mental delivery in nulliparous women who received continuous
epidural infusion (CEI) or patient-controlled epidural analgesia
(PCEA) with bupivacaine or ropivacaine [16e19]. We might reason-
ably hypothesize that different epidural infusion channels with
different local anesthetics could inﬂuence the mode of delivery. The
primary purpose of this studywas to compare themode of delivery in
nulliparous women receiving bupivacaine or ropivacaine for labor
epidural analgesia. The incidence of side effects was also assessed.Materials and methods
This is a prospective, randomized study to analyze American
Society of Anesthesiology I or II nulliparous women at term laborby Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Participant ﬂow and randomization process. ASA ¼ American Society of Anesthesiology.
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National Taiwan University Hospital from 2005 to 2006. The pro-
tocol was approved by the National Taiwan University Hospital
Institutional Review Board and written informed consent was ob-
tained from each patient before the onset of labor pain. Exclusion
criteria were multiparous women, contraindications for epidural
analgesia, drug or alcohol abuse, known fetal abnormality,
maternal obstetric complications (placenta previa and antepartum
hemorrhage), previous uterine surgery, ineffective epidural labor
analgesia [Verbal Pain Scale (VPS) S4 after an epidural loading
dose of 15 mL of the study regimen] and incomplete epidural labor
analgesia (epidural analgesia duration <2 hours). All recruited
women were in active labor with cervical dilation of 3e5 cm with
regular uterine contractions, and none received parenteral opioids
before epidural infusion. For randomization, patients blindly picked
a sealed envelope which contained a group number. Group A
received a loading dose of 10mL 1mg/mL ropivacainewith 2 mg/mLfentanyl, then an intermittent bolus dose of 5 mL with a back-
ground infusion rate at 5 mL/hour by PCEA. Group B received a
loading dose of 10 mL 0.8 mg/mL bupivacaine with 2 mg/mL fen-
tanyl, then an intermittent bolus dose of 5 mL, with a background
infusion rate at 5 mL/hour by PCEA. Group C received the same
loading dose as Group A, followed by a continuous infusion dose of
1 mg/mL ropivacaine with 2 mg/mL fentanyl at 10 mL/hour. Group D
received the same loading dose as Group B, followed by a contin-
uous infusion dose of 0.8 mg/mL bupivacainewith 2 mg/mL fentanyl
at 10 mL/hour.
Epidural analgesia was initiated after the women received 10e
15 mL/kg crystalloid solution. The randomization sequence was
generated by a table of random numbers. The results of randomi-
zation were sealed in an envelope and opened by a nurse not
participating in the study. With the patient in the left lateral po-
sition, an epidural catheter was inserted at the L3e4 lumbar region
using the loss of resistance technique; 3e4 cm of catheter was left
Table 1
Patient demographics.
Group A B C D
Number 120 120 120 120
Age 30.17  2.47 30.05  2.66 30.04  2.32 29.94  2.23
Height 159.32  2.76 159.68  2.85 159.73  2.64 160.09  2.85*
Weight 64.13  4.16 64.34  4.29 64.13  3.85 64.28  3.80
BMI 25.26  1.36 25.22  1.36 25.13  1.26 25.07  1.15
*Statistical signiﬁcance compared with Group A, p < 0.05.
BMI ¼ body mass index.
Table 3
Side effects.
A B C D
Nausea or vomiting 21 (17.5%) 19 (15.8%) 23 (19.2%) 20 (16.7%)
Central-type pruritus 74 (61.7%) 70 (58.3%) 68 (56.7%) 66 (55.0%)
Urinary retention
with catheterization
8 (6.7%) 10 (8.3%) 18 (15.0%)* 17 (14.2%)*
Drowsiness 2 (1.7%) 1 (0.8%) 3 (2.5%) 2 (1.7%)
Bromage grade 1 4 (3.3%) 5 (4.2%) 11 (9.2%) 13 (10.8%)*
*Statistical signiﬁcance compared with Group A, p < 0.05.
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epinephrine was administered through the epidural catheter. After
5 minutes of observation, the analgesia was started as described
earlier in the four groups. If any patient in any group still com-
plained of labor pain (VPS  4) after the ﬁrst loading dose, another
bolus of 5 mL of the study formula was provided. A patient would
be excluded if labor pain (VPS 4) persisted after administration of
a 15-mL loading dose from the study regimen.
We recorded and analyzed the rates of cesarean section (C/S)
and normal spontaneous delivery (NSD) with and without instru-
ment assistance, and also analyzed operative deliveries (NSD with
instrument assistance and C/S) as the predeﬁned primary study
outcome. Vacuum delivery was used in operative vaginal delivery
at our hospital throughout the study. Indications for vacuum use
were limited to inadequate voluntary pushing, maternal intoler-
ance due to health condition, dystonia without a contracted pelvis,
and problems identiﬁed on the fetal heart rate tracing, regardless of
the pain relief. Inadequate voluntary pushing was diagnosed at the
bedside as a lack of descent due to inadequate maternal expulsive
efforts [20]. Decisions about delivery methods were made by
experienced obstetricians who did not know the study formula.
There were no dramatic personnel changes among the supervisory
obstetricians during the study period. During the labor analgesic
period, complications such as nausea or vomiting, motor power
weakness, central-type pruritus, urinary retention with catheteri-
zation and drowsiness were also recorded as the predeﬁned sec-
ondary outcome. Urinary retention with catheterization was
deﬁned as the inability to void under painless labor during labor
progression and indications for a urinary catheter. Motor power
was evaluated using a modiﬁed Bromage scale (0 ¼ no motor
blockade, 1 ¼ able to ﬂex hip and knee but unable to straight leg
raise, 2 ¼ able to move ankle only, and 3 ¼ unable to move lower
limb). The incidence of motor blockadewas evaluated and recorded
by nursing staff. Demonstrable motor weakness was deﬁned as
Bromage grade 1 or above. In addition, all patients in this study had
a VPS less than 3 after starting epidural labor analgesia, to rule out
any possibility or episode of ineffective epidural analgesia.
The sample size was originally set to enroll a minimum of 70
patients in each group to assure 80% power for a two-tailed test andTable 2
Mode of delivery and analgesic groups.
Mode of delivery A B C D
Cesarean section 18 (15.0%) 20 (16.7%) 32 (26.7%)* 34 (28.3%)*,**
NSD with
instrument***
15 (12.5%) 27 (22.5%)* 17 (14.2%) 29 (24.2%)*,****
Operative (cesarean þ
NSD with instrument)
33 (27.5%) 47 (39.2%) 49 (40.8%)* 63 (52.5%)*
NSD without
instrument***
87 (72.5%) 73 (60.8%) 71 (59.2%)* 57 (47.5%)*,**
*Statistical signiﬁcance compared with Group A, p < 0.05.
**Statistical signiﬁcance compared with Group B, p < 0.05.
***Statistical signiﬁcance between Groups A þ C and B þ D, p < 0.05.
****Statistical signiﬁcance compared with Group C, p < 0.05.
NSD ¼ normal spontaneous delivery.a 0.05 signiﬁcance level. Patient and obstetric data were collected
and presented as means  standard deviations, and counts as
appropriate. Means  standard deviations were analyzed using the
unpaired Student t test for parametric data. The rates of C/S and
spontaneous delivery with or without instruments among groups
were analyzed using the Chi square test or Fisher exact test.
Results
We recruited 506 women into the study and excluded 26
women,mostly because of ineffective or incomplete analgesia. Each
group contained 120 women. The randomization process is pre-
sented in Fig. 1. Patient demographic data are shown in Table 1.
There were similar distributions of ages and weights between these
four groups. The overall C/S rate (26.7%) was signiﬁcantly higher in
patients receiving CEI in Group C than those receiving PCEA in
Group A (15.0%, p ¼ 0.02); the C/S rate in Group D (28.3%) was also
higher than in Group A (15.0%, p ¼ 0.012) and Group B (16.7%,
p ¼ 0.030). However, there was no signiﬁcant difference between
Groups A and B, or Groups C and D.
The rate of NSD with instrument assistance in Group B (22.5%)
was signiﬁcantly higher than inGroupA (12.5%, p¼ 0.04),while that
in Group D (24.2%) was higher than in Group C (14.2%, p¼ 0.049). In
addition, therewas a signiﬁcant difference between Groups A and D
(p ¼ 0.019). Group A (72.5%) had a higher rate of NSD without in-
struments than Group B with PCEA with bupivacaine/fentanyl
(60.8%,p¼0.05), GroupCwith CEIwith ropivacaine/fentanyl (59.2%,
p ¼ 0.029), and Group D with CEI with bupivacaine/fentanyl (47.5%,
p < 0.001). Table 2 shows the modes of delivery in the groups.
Urinary retention with catheterization was signiﬁcantly
different between Groups A and C (p ¼ 0.037), and Groups A and D
(p ¼ 0.05). There was no signiﬁcant difference in nausea or vom-
iting, central-type pruritus, and drowsiness. The rate of motor
weakness with Bromage grade 1 or above was similar in the groups
except for Group D, which was signiﬁcantly higher than Group A.
Table 3 shows the side effects in the groups.
An analysis of motor blockade and the mode of delivery showed
that those with operative deliveries had a higher Bromage grade
(1) than those with NSD without instruments in each group
(p < 0.05). However, there were no signiﬁcant differences in the
operative rate and motor blockade between groups (Table 4).Table 4
Mode of delivery versus motor blockade.
With/without motor blockade
(Bromage grade 1)
Mode of delivery A B C D
Operative delivery 4/29 5/42 11/38 12/51
C/S 3/15 3/17 7/25 8/26
NSD with instrument 1/14 2/25 4/13 4/25
NSD without instrument 0/87 0/42 0/71 1/56
There were statistical signiﬁcant differences between mode of delivery in each
group (p < 0.05). However, there was no statistical signiﬁcance between groups.
C/S ¼ cesarean section; NSD ¼ normal spontaneous delivery.
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Many published reports have compared the clinical efﬁcacy of
ropivacaine and bupivacaine under CEI or PCEA for labor analgesia
[6,7,9,10,12,17,21e24]. Some studied the clinical impact on the labor
course or analgesia with equivalent doses of ropivacaine and
bupivacaine with or without opioids [9,10,21,22]. Others tried to
elucidate the differences between epidural ropivacaine and bupi-
vacaine on sensory and motor blockade using VPS and modiﬁed
Bromage scores [6,7,23]. It is well-known that motor block, the
chief complication of labor epidural analgesia, might result in
prolonged labor and increase the rates of C/S and instrument-
assisted delivery [25e28]. Nevertheless, we found no study that
simultaneously compared the delivery mode for nulliparous
women using PCEA and CEI with different epidural formulas. We
therefore prospectively studied the difference among these four
different epidural labor analgesia formulas.
In previous studies, the analgesic potency ratio between ropi-
vacaine and bupivacaine was estimated to be 0.6:1.0 [29,30]. Motor
blockade with ropivacaine was 65e76% as potent as that with
bupivacaine [31]. In our hospital, we combine bupivacaine with
fentanyl for labor analgesia; however, the use of ropivacaine with
fentanyl through PCEA or CEI for epidural labor analgesia was a
completely new experience for us. We adopted the four epidural
formulas used in this study from those in previous studies
[12,13,17,22] and some conducted pilot studies.
In this study, we found that patients using PCEA (Groups A and
B) had lower rates of C/S and operative delivery compared with
those using CEI (Groups C and D). However, there were no statis-
tically signiﬁcant differences in the C/S rate between patients using
ropivacaine and bupivacaine (Groups A and B and Groups C and D).
From this information, we might infer that under effective epidural
labor analgesia, PCEA might be better than CEI for epidural labor
analgesia, when comparing the rates of C/S. The instrument-
assisted delivery rate was higher in NSD patients using bupiva-
caine (Groups B and D) than ropivacaine (Groups A and C). This
ﬁndingmatched some previous studies on the inﬂuence of epidural
analgesia with ropivacaine or bupivacaine (with/without opioids)
on the deliverymode [7,19]. However, other studies [16,17,22,26,30]
contrarily showed no signiﬁcant difference in delivery modes with
these two drugs. Furthermore, the rate of NSD without instruments
was lower in patients receiving bupivacaine than ropivacaine,
regardless of whether they used PCEA or CEI. Possibly, this is
because bupivacaine has a more intensemotor blockade and longer
effective duration, although there was no signiﬁcant correlation
between motor blockade and the mode of delivery. In addition, the
incidence of urinary catheterizationwas higher in patients with CEI
regardless of which local anesthetic they used. CEI might cause
more motor blockade than PCEA, which could give this result. CEI
with bupivacaine for labor analgesia could signiﬁcantly increase the
rates of C/S and instrument assistance in nulliparous women,
whereas the use of PCEA with ropivacaine may signiﬁcantly
decrease these rates.
In summary, we conclude that PCEA with ropivacaine could be
the best epidural labor analgesia regimen for nulliparous women
when considering the rates of C/S and instrument assistance.
Nevertheless, before we make deﬁnitive conclusions, more data
and variables should be collected to elucidate the inﬂuence of local
anesthetics on the delivery mode.
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